PDE2A was negatively correlated with tumor growth status, vascular infiltration, and promoted the HCC progression through modulating mitochondrial morphology and ATP content [42] as well influencing cell cycle of HCC [52]. The gene discussed is PDE2A; the disease is hepatocellular carcinoma.